Jutta Wanner

Dr. Wanner joined Alpha-9 as a Senior Vice President of Drug Discovery in February 2023. She brings over 20 years of experience in drug discovery, including leading small molecule and targeted drug conjugate projects as the CSO and CTO of multiple biotechnology organizations. Previously she spent a decade at Hoffmann-La Roche in a number of drug discovery roles. Dr. Wanner received her PhD from the University of Kansas and conducted her postdoctoral training at The Scripps Research Institute in San Diego.